RxDoctor Payments Data

Melissa Bramante

Nurse Practitioner · Columbia, SCNPI 1720725419

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (31.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 54.9% of the total. Reporting peaked in 2024 at $12,737 and has fallen 67.9% since, to $4,085 in 2025. Among nurse practitioner clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,599in general payments, 2019–2025

Across 209 payments — averaging $88.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$10K
  • Avadel CNS Pharmaceuticals, LLC$5K
  • Eisai Inc.$2K
  • Axsome Therapeutics, Inc.$611
  • Inspire Medical Systems, Inc.$558
  • Harmony Biosciences LLC$233
  • plus $429 from 8 others

What the payments were for

  • Consulting fees$3,65020%
  • Speaking & faculty fees$5,78831%
  • Travel & lodging$5,08927%
  • Food & beverage$3,77320%
  • Education$2982%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,599 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.

See all nurse practitioner providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
WakixPitolisant Hcl22$231,327
SunosiSolriamfetol Hcl28$23,252
BelsomraSuvorexant26$12,118
Modafinil103$12,045
NeuproRotigotine13$10,512
Armodafinil42$2,185
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine62$2,088
Gabapentin92$898
Trazodone Hcl61$772
Zolpidem Tartrate130$713
Clonazepam129$613
Zolpidem Tartrate ErZolpidem Tartrate11$564
Eszopiclone70$542
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine21$481
Zaleplon30$475

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Harmony Biosciences LLCWakix$233$231,32722 claims
Axsome Therapeutics, Inc.Sunosi$611$23,25228 claims
MerckBelsomra$27$12,11826 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.

Other nurse practitioner in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →